Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)

• मुख्य लेखकों: Park JS (लेखक), Shin JH (लेखक), Hong TJ (लेखक), Seo HS (लेखक), Shim WJ (लेखक), Baek SH (लेखक), Jeong JO (लेखक), Ahn YK (लेखक), Kang WC (लेखक), Kim YH (लेखक), Kim SH (लेखक), Hyon MS (लेखक), Choi DH (लेखक), Nam CW (लेखक), Park TH (लेखक), Lee SC (लेखक), Kim HS (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Dove Medical Press, 2016-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Jin-Sun Park,1,* Joon-Han Shin,1,* Taek-Jong Hong,2 Hong-Seog Seo,3 Wan-Joo Shim,4 Sang-Hong Baek,5 Jin-Ok Jeong,6 Youngkeun Ahn,7 Woong-Chol Kang,8 Young-Hak Kim,9 Sang-Hyun Kim,10 Min-Su Hyon,11 Dong-Hoon Choi,12 Chang-Wook Nam,13 Tae-Ho Park,14 Sang-Chol Lee,15 Hyo-Soo Kim16 1Department of Cardio...